<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01444274</url>
  </required_header>
  <id_info>
    <org_study_id>PTL-1000-0012</org_study_id>
    <nct_id>NCT01444274</nct_id>
  </id_info>
  <brief_title>Pilot Study to Evaluate A Novel Gastric Space Occupying Device</brief_title>
  <official_title>A Single-Center 60-day Observational, Non-randomized Study to Evaluate Safety and Preliminary Efficacy of a Novel Gastric Space Occupying Device as an Aid for Weight Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Obalon Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Obalon Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be an observational, prospective, non-randomized, pilot study to gain initial
      device experience on a novel space-occupying device in persons who are overweight or obese.
      No formal hypothesis testing will be conducted.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">10</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Obalon Gastric Balloon</arm_group_label>
    <description>One or two balloons administered to each patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Obalon Gastric Balloon(s)</intervention_name>
    <description>One or two balloons administered per patient</description>
    <arm_group_label>Obalon Gastric Balloon</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Overweight or obese individuals who have failed routine dieting in the past
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 21-64 years

          2. BMI 27-40 Kg/m2

          3. No history of weight reduction of more than 5% of total body weight in the past 6
             months

        Exclusion Criteria:

          1. Have unstable angina, myocardial infarction within the past year, or heart disease
             classified within the New York Heart Association's Class III or IV functional
             capacity;

          2. Be taking chronic aspirin or other non steroidal anti-inflammatory agents, or other
             medications known to be gastric irritants, and unwillingness to discontinue the use of
             these concomitant medications, antiarrythmics, anti-anginal medications,
             anticoagulants or medications for congestive heart failure;

          3. Be taking blood pressure medications, unless their blood pressure is controlled and
             they have been at stable dose for at least 3 months;

          4. Have type 1 diabetes or type 2 diabetes requiring oral medications or insulin;

          5. History or symptoms of thyroid disease which is not controlled by medication;

          6. Have severe renal, hepatic, pulmonary disease or cancer;

          7. Past history of gastrointestinal surgery (excluding uncomplicated appendectomy);

          8. Have a history of adhesive peritonitis;

          9. History or symptoms of esophageal and/or gastric varices;

         10. Have history or congenital or acquired GI anomalies (e.g. atresias, stricture, and /or
             diverticula);

         11. History or symptoms of inflammatory bowel disease, such as Chron's disease;

         12. History of/ signs and /or symptoms of duodenal or gastric ulcer;

         13. Have gastroparesis;

         14. Pregnant or breastfeeding or intention of becoming pregnant during the study (if
             female of childbearing potential);

         15. Currently using pharmaceutical agents for weight loss;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ariel Ortiz Lagardere, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Obesity Control Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Obesity Control Center</name>
      <address>
        <city>Tijuana</city>
        <state>Baja California</state>
        <zip>22320</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>September 28, 2011</study_first_submitted>
  <study_first_submitted_qc>September 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2011</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

